The roles of patient and observer assessments in anti-emetic trials
- 1 January 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (9) , 1223-1227
- https://doi.org/10.1016/0959-8049(94)90162-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapyEuropean Journal Of Cancer, 1992
- A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapyEuropean Journal Of Cancer, 1992
- Chlorpromazine and Dexamethasone versus High-Dose Metoclopramide and Dexamethasone in Patients Receiving Cancer Chemotherapy, Particularly Cis-Platinum: A Prospective Randomized Crossover StudyOncology, 1989
- A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatinCancer, 1988
- Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.Journal of Clinical Oncology, 1985
- High-dose intravenous metoclopramide and intermittent intramuscular prochlorperazine and diazepam in the management of emesis induced by cis-dichlorodiammineplatinumCancer Chemotherapy and Pharmacology, 1985
- A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomiting.Journal of Clinical Oncology, 1984